Beyond the conventional focus on amyloid protein and tau abnormalities, scientists are increasingly discovering promising pharmacological targets for Alzheimer's illness. These encompass modulating brain inflammation through inhibiting glial response, targeting neural connection impairment – particularly associated with excitatory neurotransmitte